| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 74.523 | 4.982 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8.083 |
| Total Income - EUR | 127.568 | 0 | -43.393 | 0 | 0 | 0 | 2.022 | 0 | 51.629 | 12.797 |
| Total Expenses - EUR | 122.381 | 5.103 | 2.684 | 2.635 | 1.146 | 959 | 906 | 1.943 | 11.838 | 26.367 |
| Gross Profit/Loss - EUR | 5.187 | -5.102 | -46.077 | -2.635 | -1.146 | -959 | 1.115 | -1.943 | 39.792 | -13.570 |
| Net Profit/Loss - EUR | 4.028 | -5.102 | -46.077 | -2.635 | -1.146 | -959 | 1.054 | -1.943 | 39.286 | -13.570 |
| Employees | 8 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Rv Bio Europe 77 S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 16.847 | 14.348 | 11.818 | 9.356 | 8.807 | 8.641 | 8.449 | 8.475 | 8.449 | 8.402 |
| Current Assets | 49.752 | 44.140 | 0 | -84 | 0 | 0 | 0 | 89 | 2.417 | 42.450 |
| Inventories | 49.629 | 44.140 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28.675 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10.634 |
| Cash | 123 | 0 | 0 | -84 | 0 | 0 | 0 | 89 | 2.417 | 3.141 |
| Shareholders Funds | 15.607 | 10.346 | -35.906 | -37.883 | -38.295 | -38.529 | -36.620 | -38.677 | 726 | -12.848 |
| Social Capital | 47 | 47 | 46 | 45 | 44 | 43 | 42 | 43 | 42 | 42 |
| Debts | 50.991 | 48.143 | 47.724 | 47.155 | 47.103 | 47.169 | 45.069 | 47.241 | 10.141 | 63.700 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "125 - 125" | |||||||||
| CAEN Financial Year |
125
|
|||||||||
Comments - Rv Bio Europe 77 S.r.l.